Insys founder, former executives face opioid kickback scheme trial [Reuters (UK)]
INSYS THERAPEUTICS (INSY)
Last insys therapeutics earnings: 11/5 04:16 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.insysrx.com
Company Research
Source: Reuters
Insys founder, former executives face opioid kickback scheme trial | Reuters 3 Min Read BOSTON (Reuters) - The one-time billionaire founder of Insys Therapeutics Inc and four other former executives and managers of the opioid drugmaker will face trial over charges they conspired to pay doctors bribes to prescribe patients an addictive fentanyl spray to boost sales. Lawyers are set to deliver opening statements Monday in federal court in Boston in the case of former Insys chairman John Kapoor, the highest-level executive of a painkiller manufacturer to be tried amid a deadly U.S. opioid abuse epidemic. Prosecutors say Kapoor directed a kickback scheme that helped fuel the epidemic in order to boost the company’s sales of Subsys, an under-the-tongue fentanyl spray approved only for use in managing severe pain in cancer patients. Fentanyl is an opioid 100 times stronger than morphine. Net revenues for Subsys grew from $8.6 million in 2012 to $329 million in 2015, according to Insys. Kapo
Show less
Read more
Impact Snapshot
Event Time:
INSY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INSY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INSY alerts
High impacting INSYS THERAPEUTICS news events
Weekly update
A roundup of the hottest topics